NEXT-ChemX Corporation. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NEXT-ChemX Corporation. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2016 | $1.5K | Apr 19, 2018 |
| FY2016 | Dec 31, 2015 | $0 | Apr 17, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $1.4K | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $14.7K | Jun 18, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $1.4K | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $14.7K | Jun 18, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.81M) | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | ($2.51M) | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | ($1.74M) | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | ($1.78M) | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | $345.0K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($139.8K) | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | ($70.7K) | Jun 18, 2020 |
| FY2018 | Dec 31, 2017 | ($33.3K) | Apr 11, 2019 |
| FY2017 | Dec 31, 2016 | ($38.9K) | Apr 19, 2018 |
| FY2016 | Dec 31, 2015 | ($773) | Apr 17, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.73M) | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | ($2.13M) | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | ($1.67M) | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | ($1.77M) | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | ($118.3K) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($101.0K) | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | ($76.7K) | Jun 18, 2020 |
| FY2018 | Dec 31, 2017 | ($33.3K) | Apr 11, 2019 |
| FY2017 | Dec 31, 2016 | ($38.9K) | Apr 19, 2018 |
| FY2016 | Dec 31, 2015 | ($773) | Apr 17, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.53M) | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | ($544.9K) | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | ($935.1K) | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | ($703.5K) | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | $183.5K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $377.0K | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | ($34.5K) | Jun 18, 2020 |
| FY2018 | Dec 31, 2017 | ($35.4K) | Apr 11, 2019 |
| FY2017 | Dec 31, 2016 | ($40.2K) | Apr 19, 2018 |
| FY2016 | Dec 31, 2015 | ($773) | Apr 17, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $1.6K | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | $24.1K | Apr 21, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.25M | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | $2.84M | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | $3.22M | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | $3.18M | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | $46.8K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $515.4K | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $83.9K | Jun 18, 2020 |
| FY2018 | Dec 31, 2017 | $13.2K | Apr 11, 2019 |
| FY2017 | Dec 31, 2016 | $6.9K | Apr 19, 2018 |
| FY2016 | Dec 31, 2015 | $6.1K | Apr 17, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.16M | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | $3.93M | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | $2.49M | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | $1.47M | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | $201.2K | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | $667.2K | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $80.1K | Jun 18, 2020 |
| FY2018 | Dec 31, 2017 | $43.4K | Apr 11, 2019 |
| FY2017 | Dec 31, 2016 | $13.5K | Apr 19, 2018 |
| FY2016 | Dec 31, 2015 | $1.5K | Apr 17, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($2.90M) | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | ($1.09M) | Apr 30, 2025 |
| FY2024 | Dec 31, 2022 | $731.9K | Apr 30, 2025 |
| FY2023 | Dec 31, 2021 | $1.71M | Apr 28, 2025 |
| FY2022 | Dec 31, 2020 | ($154.4K) | Apr 21, 2023 |
| FY2021 | Dec 31, 2019 | ($151.8K) | Apr 15, 2022 |
| FY2019 | Dec 31, 2018 | $20.5K | Jun 18, 2020 |
| FY2018 | Dec 31, 2017 | ($30.3K) | Apr 11, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($8.33M) | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | ($6.51M) | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | ($3.69M) | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | ($1.95M) | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | ($164.6K) | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | ($282.6K) | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | ($142.8K) | Jun 18, 2020 |
| FY2018 | Dec 31, 2017 | ($72.1K) | Apr 11, 2019 |
| FY2017 | Dec 31, 2016 | ($38.8K) | Apr 19, 2018 |
| FY2016 | Dec 31, 2015 | ($1.4K) | Apr 17, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $44.6K | Apr 8, 2021 |
| FY2020 | Dec 31, 2019 | $567 | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $69.2K | Jun 18, 2020 |
| FY2018 | Dec 31, 2017 | $6.5K | Apr 11, 2019 |
| FY2018 | Dec 31, 2016 | $207 | Apr 11, 2019 |
| FY2017 | Dec 31, 2015 | $6.1K | Apr 19, 2018 |
| FY2016 | Dec 31, 2014 | $6.1K | Apr 17, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | 0 | Apr 21, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 28, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 28.55M | Apr 30, 2025 |
| FY2024 | Dec 31, 2023 | 28.55M | Apr 30, 2025 |
| FY2023 | Dec 31, 2022 | 28.35M | Apr 28, 2025 |
| FY2022 | Dec 31, 2021 | 27.39M | Apr 21, 2023 |
| FY2021 | Dec 31, 2020 | 8.96M | Apr 15, 2022 |
| FY2020 | Dec 31, 2019 | 8.96M | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | 8.94M | Jun 18, 2020 |
| FY2018 | Dec 31, 2017 | 8.62M | Apr 11, 2019 |
| FY2017 | Dec 31, 2016 | 8.62M | Apr 19, 2018 |
| FY2016 | Dec 31, 2015 | 6.00M | Apr 17, 2017 |